SCHEMBL2270927

SCHEMBL2270927

CN1CCC(CNc2cccc(S(=O)(=O)n3ccc4ccccc43)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 15/20 0.52
HTT P42858 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
HTR1A P08908 2/20 0.47
DRD2 P14416 2/20 0.47
CYP3A4 P08684 2/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2348423 0.88 HTR6 (0.51) HTR6CYP3A4HTR2A
SCHEMBL2355547 0.86 HTR6 (0.56) HTR6MEN1KMT2ACYP3A4HDAC3
SCHEMBL2272672 0.85 HTR6 (0.60) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL2364434 0.84 HTR6 (0.48) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL2348660 0.79 HTR6 (0.50) HTR6CYP3A4
SCHEMBL2276061 0.77 HTR6 (0.63) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL1975488 0.77 HTR6 (0.51) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL4629453 0.76 JAK1 (0.41) HTR6HTR1ADRD2HTR2A
SCHEMBL1356485 0.74 HTR6 (0.74) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL2273734 0.73 HTR6 (0.54) HTR6HTTMEN1KMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998981-B2 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-16 US claimed
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES, LTD. (IN) 2010-07-01 US claimed
EP-1919896-B1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LTD (IN) 2009-12-23 EP claimed
US-7998981-B2 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-16 US disclosed
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES, LTD. (IN) 2010-07-01 US disclosed
EP-1919896-B1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LTD (IN) 2009-12-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands HTR6, HTR5A, HTR3B HTR6 1/4885HTT 492/4885MEN1 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.